Targeting Trends 2000 Newsletter

CBF Lesioning in Rabbits / by Beach T / featuring ME20.4-SAP, Cat. #IT-15 Chronic Pain Therapeutic NIDA funds ATS research on Galanin Recent Scientific References Targeting Talk: Second Immunotoxins Targeting Tools: New Products Mouse-Specific p75 Immunotoxin (Cat. #IT-16) ME20.4 Monoclonal and Immunotoxin (Cat. #IT-15, Cat. #AB-N07)

Targeting Tools: ME20.4 Monoclonal and Immunotoxin

The ME20.4 monoclonal antibody (Cat. #AB-N07) was derived from immunization of mice with WM245 melanoma cells. The antibody can be used in Western blot, immunoprecipitation, immunohistochemistry, FACS analysis, and electron microscopy. The known species reactivity includes human, primate, rabbit, raccoon, dog, cat, and sheep. The ME20.4-SAP immunotoxin (Cat. #IT-15) is a chemical conjugation between the …

Targeting Tools: ME20.4 Monoclonal and Immunotoxin Read More »

Targeting Talk: Second Immunotoxins

What is a second immunotoxin? ATS’s second immunotoxins are conjugations of a secondary antibody (as of December 2000, either goat anti-mouse IgG or goat anti-rabbit IgG) to the ribosome-inactivating protein, saporin. How does a second immunotoxin target? The second immunotoxin uses the secondary antibody to “piggyback” onto your primary antibody in order to evaluate the …

Targeting Talk: Second Immunotoxins Read More »

NIDA funds ATS research on Galanin

Advanced Targeting Systems (ATS) has just been awarded a $100,000 research grant from the National Institute on Drug Abuse (NIDA). This Phase I SBIR (Small Business Innovation Research) grant proposes to develop a research reagent to study the function of the neuropeptide, galanin. This will be an important tool for scientists to use in the …

NIDA funds ATS research on Galanin Read More »

Cover Article: CBF Lesioning in Rabbits

Contributed by Dr. Thomas Beach, Sun Health Research Institute, Sun City, AZ Our hypothesis, developed through our own human and animal studies1-6 and the cell culture work of others (beginning with Nitsch7), is that the normal, age-related loss of cortical cholinergic innervation leads to Aβ deposition and Alzheimer’s disease. To test this hypothesis, we have been …

Cover Article: CBF Lesioning in Rabbits Read More »